Skip to content
Psychedelics Today cover art

All Episodes

Psychedelics Today — 779 episodes · page 2 of 8

#
Title
101

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

102

PT560 – Philosophy and Psychedelics: Can Metaphysics Bring Meaning to Non-Ordinary States?, with Dr. Peter Sjöstedt-Hughes

103

PT559 – The Penn Psychedelics Collaborative and the Power of Interdisciplinary Connections, with Taylor Andrews Flatt, PMHNP, Victor Pablo Acero, Ph.D., Jackie Tileston, and Michael Baime, MD

104

PT558 – What You Need to Know About Massachusetts' Question 4 and the Natural Psychedelic Substances Act, with Graham Moore and Jamie Morey

105

PT557 – Psychedelic Education Through a Healing Justice Lens, with Diana Quinn, ND

106

PT556 – The FDA, MDMA, and Public Perception: Was the FDA Fair to Lykos?, with Rick Doblin, Ph.D.

107

PT555 – Protecting Indigenous Wisdom: Rethinking Psychedelic Legalization, with Gabriela Galindo

108

PT554 – The Hero's Journey: Finding Your Story in Psychedelic Healing, with Mareesa Stertz

109

PT553 – Healing Psychedelics: Where Science Meets Spirit, with Micah Stover & Craig Heacock, MD

110

PT552 – The Globalization of Ayahuasca, Psychedelic Parenting, and the Power of Ceremony, with Glauber Assis, Ph.D.

111

PT551 – Tripped: The Connection Between LSD, Nazi Germany, and MKUltra, with Norman Ohler

112

PT550 – Intention, Making Space for Integration, and Finding Joy in the Mundane, with Lana Pribic, M.Sc, CPC

113

PT549 – Why Did the FDA Reject MDMA-Assisted Therapy for PTSD?, with Ingmar Gorman, Ph.D.

114

PT548 – Finding Your Soul's Purpose: Harnessing Psychedelic Insights for Professional Growth, with Beth Weinstein

115

PT547 – Coaching, Fractal Inquiry, and How to Create Your Own Psychedelic Integration Circle, with Daniel Shankin

116

PT546 – Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters, with Joanna Kempner, Ph.D.

117

PT545 – Breathwork, Holding Space, and the Healing Power of Connection: Documenting the Dreamshadow Community, with Mustapha Khan

118

PT544 – Psychedelics and Addiction Recovery: Microdosing and Redefining the Path to Sobriety, with Danielle Nova

119

PT543 – Empathy and Agency: Why Psychedelic Practitioners Need to be Trauma-Informed, with Deanna Rogers

120

PT542 – The Illinois CURE Act: Shaping the Future of Psychedelic Policy, with Jean Lacy & Representative La Shawn K. Ford

121

PT541 – Regenerative Economics and Psychedelics: Creating More Connected Leadership, with Rachelle Sampson, Ph.D. & Bennet Zelner, Ph.D.

122

PT540 – Ancestral Teachings for the Psychedelic Renaissance, with Alonso Del Río & Francisco Rivarola

123

PT539 – Buddhist Philosophy, Shadow Work, and Integrating a Psychedelic Experience, with Kate Amy

124

PT538 – Rumination, the Default Mode Network, and How Neuroplasticity Changes Over Time, with Dr. Jerry Rosenbaum & Sharmin Ghaznavi, MD, Ph.D.

125

PT537 – Microdosing at Work: How Psychedelics are Creating Better Leaders, with Tiffany Hurd

126

PT536 – Psychedelics and Creativity, Endo-Tripping, and the Origins of Life on Earth, with Dr. Bruce Damer

127

PT535 – Jungian Psychology, Psychedelics, and the Multiplicity of Self, with Maria Papaspyrou & Dr. Ido Cohen

128

PT534 – Exploring the Fungal Kingdom: Cultivation, Connection, and the Potential of Permaculture, with Jasper Degenaars

129

PT533 – Psychedelics in Palliative Care: Screening, Safety Measures, and Experiences With the Divine, with Livi Joy

130

PT532 – Understanding Bad Trips: The Power and Potential of Adverse Psychedelic Experiences, with Erica Rex, MA

131

PT531 – Ecopsychology, Plant Dietas, and Plant Consciousness: Building a Relationship with Nature, with Monica Nieto and Jordana Ma

132

PT530 – Meditation, Exploring Spiritual Traditions, and the Wisdom of Plant Medicine, with Jon Reiss

133

PT529 – Difficult Conversations, the Need for Culturally Competent Care, and Why Representation Matters, with Sara Reed & Alex H. Robinson

134

PT528 – Chronic Pain and Inducing Neuroplasticity With Psychedelics, with Lynn Watkins, Retired USAF, and C.J. Spotswood, PMHNP

135

PT527 – Symptoms as Signals: Trauma and the Role of Inner Healing Intelligence, with Casey Paleos, MD

136

PT526 – Transforming Trauma: Community, Connection, and the Healing Power of Vulnerability, with Peter A. Levine, Ph.D.

137

PT525 – Women and Psychedelics: History's Untold Stories, with Erika Dyck

138

PT524 – Building a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access, with Lia Mix, LMFT, CPTR

139

PT523 – Self-Care, Destabilization, and the Holistic Nature of Psychedelics, with Kaitlin Roberson & Dr. Michele Cox, DO

140

PT522 – An Inside look at the FDA and Early Drug Development, with Dr. Amanda Holley

141

PT521 – Community, Group Process, and Co-Creation: How to Build a Successful Retreat, with Alice Dommert & Kara Tremain, ACC

142

PT520 – From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion in the Psychedelic Experience, with Charles Stang

143

PT519 – Exploring Somatic Practices and Psychedelics, with Pierre Bouchard, LPC & Kara Tremain, ACC

144

PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.

145

PT517 – Long COVID and Psychedelics, Monica Verduzco-Gutierrez, MD, Joel Castellanos, MD, & MaryAnn Welke Lesage

146

PT516 – Embracing the Mystery: Making Psychedelic Literature Engaging, with Sean Lawlor

147

PT515 – The Economics of Psychedelics, with Elliot Marseille, DrPH, MPP

148

PT514 – Breaking Through Bureaucracy: Can D.C. Embrace Evidence-Based Drug Policy?, with Senator Tom Daschle and Charlie Panfil

149

PT513 – Depth Psychology, Archetypal Energies, and How Psychedelics Reveal the Soul, with Simon Yugler

150

PT512 – RIPPLES of Hope: Psychedelics as a Tool for Peacebuilding and Collective Healing, with Sami Awad and Leor Roseman, Ph.D.

151

PT511 – The Other Side of Veteran Healing: Secondary PTSD and Post-Retreat Family Dynamics, with Allison Wilson & Dr. Grace Blest-Hopley

152

PT510 – Early Research, Psychedelics in Palliative Care, and the Intersection of Science and the Sacred, with William Richards, STM, Ph.D.

153

PT509 – Music for Psychedelic Exploration, and the First 'Choose Your Own Adventure' Album

154

PT508 – The Veteran Community and Operator Syndrome: Psychedelics and Redefining Pain Management, with Tommy Aceto

155

PT507 – Psychedelic Education: Insights, Advice, and Where to Start, with Johanna Hilla & Kyle Buller

156

PT506 – Decolonization, Difficult Conversations, and the Challenge of Merging Spirituality and Science, with Philip Wolf

157

PT505 – Bicycle day Reflections, Quantum Mechanics, and the Value in Studying Philosophy to Understand Psychedelic Experiences, with Lenny Gibson, Ph.D.

158

PT504 – Rethinking Drug Education: From D.A.R.E. Scare Tactics to an Evidence-Based Approach, with Joey Lichter, Ph.D.

159

PT503 – Updates from MAPS: Current Initiatives, Psychedelic Science 2025, and Music as a Bridge, with Devon Phillips

160

PT502 – Preserving Psychedelic Legacies: Shulgin Farm and the Shulgin Archive Project, with Keeper Trout

161

PT501 – Women and Psychedelics, Microdosing, and the Challenges of Psychedelic Parenthood, with April Pride

162

PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.

163

PT499 – Osiris González Romero – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological Turn

164

PT498 – Maria Mangini, Ph.D., FNP – Traversing the Psychedelic Landscape: From Esalen and Millbrook to the Future of Shulgin Farm

165

PT497 – Wendy Tucker – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit of Discovery

166

PT496 – Juan Pablo Cappello – Maintenance Doses and Recurring Revenue: The Ethics of At-Home Ketamine Therapy

167

PT495 – Dr. 1Drea Pennington Wasio – Self-Love, Narrative Therapy, and Post-Traumatic Growth

168

PT494 – Itzhak Beery – Soul Retrieval, Moments of Awakening, and Uncovering the Language of Spirit

169

PT493 – Laura Reeves – Sacred Sites, Ayahuasca, and Connecting With the Rhythms of the Earth

170

PT492 – Elizabeth Anglin – Alien Abductions and Parallel Realities: How Do You Validate the Radically Ineffable?

171

PT491 – Dr. Sam Banister – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic Compounds

172

PT490 – Dr. Robin Carhart-Harris – Plasticity, the Role of Set and Setting, and the Influence of Psychedelics

173

PT489 – Alyssa Gursky, LPC – Psychedelics, Art Therapy, and the Creative Process

174

PT488 – Matthew 'Whiz' Buckley – The Cost of War: Veterans' Mental Health and Government Responsibility

175

PT487 – Saga Briggs – Interoception, Healing Through Connection, and Learning to Trust Our Bodies

176

PT486 – Steve Rio – 5-MeO-DMT, Somatic Release, and Creating Context for Spirituality

177

PT485 – Ayize Jama-Everett, M.Div, M.A., M.F.A. – Meeting People Where They Are: Why the Underground Will Always Thrive

178

PT484 – Dr. Peter Grinspoon – Seeing Through the Smoke: The Importance of Telling the Truth About Cannabis

179

PT483 – Dr. Kate Pate – Traumatic Brain Injuries, the Gut Microbiome, and the Potential of Psychedelics as Anti-Inflammatory Agents

180

PT482 – Paul F. Austin – Behind the Scenes: A Conversation on Psychedelic Business, Media, and Education

181

PT481 – Ryan Latreille – Kanna: The History, Science, and Potential of an Emerging Legal Alternative

182

PT480 – Emma Knighton – Psychedelics and Consent: Power Dynamics, Boundaries, and the Concept of 'Safe Enough'

183

PT479 – Erik Vaughan – Psilocybin in the Midwest and the Need for Potency Testing

184

PT478 – Christine Calvert, LCDC – Holotropic Breathwork as a Stepping Stone, Complementary Therapy, and Teacher

185

PT477 – Kaci Hohmann & Dave Kopilak – Oregon Measure 109: The Possibilities of Service Centers & What Businesses Should Consider

186

PT476 – Mike Margolies – Reinventing Organizations, Lessons From Burning Man, and Batman & The Joker

187

PT475 – Christine Caldwell & Mary Telliano – End-of-Life Care and Psychedelics: The Role of a Death Doula

188

PT474 – Joe Moore & Kyle Buller – The Origin of Psychedelics Today and the Growth of Vital

189

PT473 – Kayse Gehret – Microdosing for Healing: The Importance of Journaling and Group Process

190

PT472 – Mike Finoia – Psychedelics and Comedy: Finding the Humor in Personal Growth

191

PT471 – Stanislav and Brigitte Grof – The Evolution of LSD Psychotherapy, the Power of Breathwork, and Why We Should be Taking Archetypal Astrology More Seriously

192

PT470 – Angie Leek, LMFT/LPC-S, SEP & Justin LaPree – Wounded Healers and the Power of Community in the Veteran Space

193

PT469 – Mason Marks, MD, JD – Drug Policy in 2023: The FDA's Guidance for Clinical Trials, The Natural Medicine Act, and SB-303

194

PT468 – Flor Bollini – Personalized Medicine, Biohacking, and Reconnecting to the Source

195

PT467 – Daan Keiman, MA, Rabbi Aura Ahuvia, & Josh Harper – The Role of Religion, Psychedelic Chaplaincy, and Spiritual Care

196

PT466 – John H. Buchanan, Ph.D. – The Philosophy of Alfred North Whitehead: Understanding Reality and the Psychedelic Experience

197

PT465 – Shauheen Etminan, Ph.D. & Jonathan Lu – Beta-carbolines, Haoma, and Syrian Rue: Rediscovering Ancestral Knowledge

198

PT464 – Bessel van der Kolk, MD – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and Body Connection

199

PT463 – Dana Lerman, MD – Bringing Intention, Ceremony, and Inner Healing Intelligence to Modern Medicine

200

PT462 – Dr. Dave Rabin, MD, Ph.D. – Touch Therapy, Wearable Technology, and Treating Trauma with Safety